Hemo Organic [HEMORGANIC] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison
Hemo Organic
BSE
Loading...
Sun Pharma Advanced
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Hemo Organic wins in 13 metrics, Sun Pharma Advanced wins in 5 metrics, with 0 ties. Hemo Organic appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Hemo Organic | Sun Pharma Advanced | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 44.87 | -13.68 | Sun Pharma Advanced |
| Price-to-Book Ratio | -21.72 | -21.57 | Hemo Organic |
| Debt-to-Equity Ratio | -9.77 | -1.24 | Hemo Organic |
| PEG Ratio | 0.02 | 0.30 | Hemo Organic |
| EV/EBITDA | 184.53 | -17.40 | Sun Pharma Advanced |
| Profit Margin (TTM) | 3.28% | -53.22% | Hemo Organic |
| Operating Margin (TTM) | -6,026.32% | -568.05% | Sun Pharma Advanced |
| Return on Equity | -108.18% | 157.88% | Sun Pharma Advanced |
| Return on Assets (TTM) | 3.29% | -102.08% | Hemo Organic |
| Free Cash Flow (TTM) | $-3.62M | $-3.71B | Hemo Organic |
| 1-Year Return | -20.17% | -34.40% | Hemo Organic |
| Price-to-Sales Ratio (TTM) | 1.44 | 72.37 | Hemo Organic |
| Enterprise Value | $47.24M | $49.34B | Sun Pharma Advanced |
| EV/Revenue Ratio | 1.90 | 76.39 | Hemo Organic |
| Gross Profit Margin (TTM) | 26.32% | -10.68% | Hemo Organic |
| Revenue per Share (TTM) | $7 | $2 | Hemo Organic |
| Earnings per Share (Diluted) | $0.23 | $-9.19 | Hemo Organic |
| Beta (Stock Volatility) | -0.06 | 0.30 | Hemo Organic |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Hemo Organic vs Sun Pharma Advanced Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Hemo Organic | -9.83% | -2.42% | -4.34% | -11.05% | -0.75% | -18.99% |
| Sun Pharma Advanced | -0.41% | 0.13% | -2.56% | -4.87% | 9.93% | -28.61% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Hemo Organic | -20.17% | -59.74% | -20.17% | -56.11% | -92.59% | 39.04% |
| Sun Pharma Advanced | -34.40% | -34.02% | -14.84% | -62.71% | 58.53% | -50.71% |
News Based Sentiment: Hemo Organic vs Sun Pharma Advanced
Hemo Organic
News sentiment data is not available for Hemo Organic at this time.
Sun Pharma Advanced
News based Sentiment: MIXED
September presented a mixed bag for SPARC, with disappointing financial results offset by a significant analyst upgrade and fluctuating share prices. While the company continues to struggle with revenue and profitability, the positive sentiment from analysts suggests potential for future turnaround, making it a noteworthy month for investors.
Performance & Financial Health Analysis: Hemo Organic vs Sun Pharma Advanced
| Metric | HEMORGANIC | SPARC |
|---|---|---|
| Market Information | ||
| Market Cap | ₹33.48M | ₹46.74B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 3,947 | 205,981 |
| 90 Day Avg. Volume | 2,540 | 222,297 |
| Last Close | ₹9.26 | ₹143.28 |
| 52 Week Range | ₹8.05 - ₹13.70 | ₹109.30 - ₹241.00 |
| % from 52W High | -32.41% | -40.55% |
| All-Time High | ₹2,386.00 (Apr 21, 2008) | ₹875.00 (Apr 24, 2006) |
| % from All-Time High | -99.61% | -83.63% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -1.00% | -0.43% |
| Quarterly Earnings Growth | N/A | -0.43% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | -0.53% |
| Operating Margin (TTM) | -60.26% | -5.68% |
| Return on Equity (TTM) | -1.08% | 1.58% |
| Debt to Equity (MRQ) | -9.77 | -1.24 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹-0.44 | ₹-6.69 |
| Cash per Share (MRQ) | ₹0.03 | ₹0.06 |
| Operating Cash Flow (TTM) | ₹-38,918,000 | ₹-3,484,287,000 |
| Levered Free Cash Flow (TTM) | ₹1.64M | ₹-3,425,094,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Hemo Organic vs Sun Pharma Advanced
| Metric | HEMORGANIC | SPARC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 44.87 | -13.68 |
| Forward P/E | N/A | 2.60 |
| PEG Ratio | 0.02 | 0.30 |
| Price to Sales (TTM) | 1.44 | 72.37 |
| Price to Book (MRQ) | -21.72 | -21.57 |
| Market Capitalization | ||
| Market Capitalization | ₹33.48M | ₹46.74B |
| Enterprise Value | ₹47.24M | ₹49.34B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.90 | 76.39 |
| Enterprise to EBITDA | 184.53 | -17.40 |
| Risk & Other Metrics | ||
| Beta | -0.06 | 0.30 |
| Book Value per Share (MRQ) | ₹-0.44 | ₹-6.69 |
Financial Statements Comparison: Hemo Organic vs Sun Pharma Advanced
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HEMORGANIC | SPARC |
|---|---|---|
| Revenue/Sales | ₹19,000 | ₹96.40M |
| Cost of Goods Sold | ₹14,000 | ₹106.70M |
| Gross Profit | ₹5,000 | ₹-10.30M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-1.15M | ₹-547.60M |
| EBITDA | ₹-1.14M | ₹-429.40M |
| Pre-Tax Income | ₹-1.15M | ₹-518.10M |
| Income Tax | ₹-288,000 | ₹600,000 |
| Net Income (Profit) | ₹-857,000 | ₹-518.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HEMORGANIC | SPARC |
|---|---|---|
| Cash & Equivalents | ₹87,000 | ₹19.64M |
| Total Current Assets | ₹46.94M | ₹261.97M |
| Total Current Liabilities | ₹36.47M | ₹3.74B |
| Long-Term Debt | ₹14.80M | ₹1.07B |
| Total Shareholders Equity | ₹-1.52M | ₹-2.17B |
| Retained Earnings | N/A | ₹-23.22B |
| Property, Plant & Equipment | ₹20,000 | ₹178.02M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HEMORGANIC | SPARC |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | HEMORGANIC | SPARC |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 3,947 | 205,981 |
| Average Daily Volume (90 Day) | 2,540 | 222,297 |
| Shares Outstanding | 3.47M | 324.52M |
| Float Shares | 1.92M | 91.74M |
| % Held by Insiders | 0.42% | 0.73% |
| % Held by Institutions | 0.00% | 0.02% |
Dividend Analysis & Yield Comparison: Hemo Organic vs Sun Pharma Advanced
| Metric | HEMORGANIC | SPARC |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |